Toronto, Ontario–(Newsfile Corp. – March 7, 2025) – DGTL Holdings Inc. (TSXV: DGTL) (“DGTL” or the “Company”) reports the closing of a non-brokered private placement financing (the “Offering”) resulting in the issuance of 5,544,344 common shares (each a “Share”) at a price of $.045 per share.
All securities issued pursuant to the Offering will be subject to a mandatory trading restriction period of four months and one day from the date of issuance. Gross proceeds will be dedicated to working capital. No one specific use of proceeds will represent 10% or more of the proceeds nor will any proceeds be used for investor relations activities.
The Company also reports a related party participation in the Offering with 1,388,889 common shares being acquired by CEO and Chairman John Belfontaine. The Company notes a reliance on exemptions from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption contained in section 5.7(a) of MI 61-101 as the fair market value of the related party transaction does not exceed more than the 25% of the Company’s total market capitalization. For more information contact:
—–
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/243839
View more news from DGTL Holdings Inc.
You are receiving this email because you have previously indicated your interest in receiving news for DGTL Holdings Inc.
If you no longer want to receive messages from us, you can click here to unsubscribe.
Anti-Spam Policy | Privacy Policy
The post DGTL Holdings Inc. Reports Closing of Private Placement Financing first appeared on PressReleaseCC.
DGTL Holdings Inc. Reports Closing of Private Placement Financing first appeared on Web and IT News.
EdgeTI Announces Non-Brokered Proposed Private Placement of C$10,000,000 via Convertible Debenture Units $10,000,000 Million CAD…
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board A…
ALUULA Reports Record Q4 2025 Sales with $6M+ Pipeline of Binding Purchase Agreements; Plans to…
Evertz Technologies Reports Quarterly Revenue of $132.7 Million in the Second Quarter Ended October 31,…
NEW YORK, N.Y., Dec. 10, 2025 (PRESSRELEASECC.COM NEWSWIRE) — iToolab, a leading provider of innovative…
NEW YORK, N.Y., Dec. 10, 2025 (PRESSRELEASECC.COM NEWSWIRE) — This holiday season, HitPaw Edimakor, the…
This website uses cookies.